Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

Clinical trial NCT05135091 · RECRUITING

Trial details

NCT number: NCT05135091
Sponsor: Neurona Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Mesial Temporal Lobe Epilepsy

Start date: 2022-06-16
Primary completion: 2029-02-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.